Carelessweed Allergy: A Major Fall Aeroallergen in the Great Plains
Carelessweed allergy is an IgE-mediated reaction to Ambrosia psilostachya, a wind-pollinated weed in the Asteraceae family that is a dominant fall aeroallergen across the US Great Plains and Southwest. It affects millions of people in the central US, where it produces large quantities of highly allergenic pollen from August through October. Symptoms include sneezing, nasal congestion, itchy eyes, and asthma exacerbations. Evidence-based management combines avoidance, pharmacotherapy, and allergen immunotherapy targeting the shared Amb a 1 allergen.
Free · 5 min · Insurance accepted
What Is Carelessweed Allergy?
Carelessweed allergy is a seasonal IgE-mediated respiratory allergy to the pollen of Ambrosia psilostachya, a wind-pollinated perennial weed in the Asteraceae (daisy) family that is a dominant fall aeroallergen across the US Great Plains, Southwest, and Rocky Mountain regions.
The plant is also known as western ragweed or perennial ragweed, and it is one of several Ambrosia species that together produce the most clinically significant weed pollen in North America.
Carelessweed is particularly problematic because it is a perennial — unlike common ragweed (Ambrosia artemisiifolia), which is an annual that must re-seed each year, carelessweed spreads through underground rhizomes and can persist and expand its territory year after year. It produces large quantities of lightweight, wind-dispersed pollen from August through October, overlapping substantially with the common ragweed season. The major allergen, Amb a 1, is a pectate lyase protein that is structurally and immunologically similar to the Amb a 1 allergen from common ragweed, meaning that patients sensitized to one Ambrosia species are almost always cross-reactive to the others.
Symptoms of Carelessweed Allergy
Recognizing symptoms early helps you get the right treatment faster.
Sneezing
mildRepetitive, paroxysmal sneezing is a hallmark of IgE-mediated pollinosis; most pronounced during peak pollen hours.
Nasal congestion
moderateMucosal edema from histamine release causes nasal blockage and pressure; often worse at night, disrupting sleep.
Runny nose (rhinorrhea)
mildWatery, clear nasal discharge is a classic symptom of allergic rhinitis triggered by inhaled pollen.
Itchy, watery eyes
mildAllergic conjunctivitis with bilateral itching, tearing, and redness is common in pollen-sensitized individuals.
Palate and ear itch
mildA deep, persistent itch in the roof of the mouth or ear canals is characteristic of tree and weed pollen allergy.
Post-nasal drip and cough
mildMucus draining from the nasal passages into the throat causes throat clearing, cough, and a sensation of a lump in the throat.
Fatigue and brain fog
moderatePoor sleep quality from nocturnal congestion and the systemic inflammatory response to pollen exposure can cause significant daytime fatigue and reduced concentration.
Asthma exacerbation
severeWheezing, chest tightness, and shortness of breath can occur in patients with comorbid asthma during peak pollen season.
Oral allergy syndrome
mildTingling, itching, or mild swelling of the lips, mouth, or throat when eating raw melons, bananas, or zucchini due to cross-reactivity with Amb a 1.
When to see a doctor
Carelessweed allergy produces classic IgE-mediated rhinoconjunctivitis symptoms identical to those caused by common ragweed. The primary symptoms are sneezing, nasal congestion, runny nose, itchy and watery eyes, and itchy palate or throat. Because the Amb a 1 allergen is shared across Ambrosia species, patients with carelessweed allergy experience the same symptom profile as ragweed allergy — just during a slightly different geographic and temporal window. In the Great Plains, where carelessweed is the dominant fall weed, symptoms can be particularly severe due to the high pollen load. Patients may experience significant sleep disruption from nocturnal nasal congestion, fatigue from poor sleep quality, and reduced productivity during the workday. Asthma exacerbations are common in patients with comorbid asthma, with emergency department visits for asthma increasing during the fall pollen season. Some patients may also experience oral allergy syndrome when eating certain raw fruits and vegetables — particularly melons, bananas, and zucchini — due to cross-reactivity between Amb a 1 and homologous proteins in these foods. If you experience throat tightening, facial swelling, or difficulty breathing, seek emergency care immediately.
Carelessweed and Asthma Risk
Carelessweed pollen is a well-established trigger for asthma exacerbations in sensitized patients. The Amb a 1 allergen, when inhaled, can reach the lower airways and trigger bronchoconstriction in patients with allergic asthma. Studies of ragweed pollen (which shares the same major allergen) demonstrate that emergency department visits for asthma increase by 10–30% during the fall pollen season, and hospitalizations for asthma peak in September — a phenomenon known as 'September asthma epidemic' in regions where Ambrosia species are dominant. For patients with known asthma living in the Great Plains, the August–October carelessweed season represents a predictable high-risk period. Pre-treatment with controller medications, close monitoring of peak flow, and a written asthma action plan are essential. Patients who experience wheezing, chest tightness, or shortness of breath during the fall pollen season should discuss these symptoms with their allergist, as they may indicate that asthma is not adequately controlled.
Potential Complications of Carelessweed Allergy
Untreated seasonal allergic rhinitis from carelessweed pollen can progress to several clinically significant complications over time. Chronic nasal inflammation impairs mucociliary clearance, creating conditions that favor secondary bacterial sinusitis — characterized by facial pain, thick discolored nasal discharge, and reduced sense of smell. Nasal polyps can develop in patients with chronic allergic inflammation, further obstructing nasal passages and impairing sense of smell. The most serious complication is asthma development or exacerbation. The atopic march — the progression from allergic rhinitis to asthma — is well documented in patients with untreated pollen allergy. For patients who already have asthma, the fall pollen season is a predictable trigger for exacerbations that may require emergency care or hospitalization. Sleep disruption from nocturnal nasal congestion leads to daytime fatigue, reduced work or school productivity, and impaired quality of life. Children with untreated fall allergies may experience worsened academic performance during the back-to-school period. Oral allergy syndrome from cross-reactive foods is typically mild but can cause dietary restriction and anxiety in affected patients.
Chronic sinusitis
Persistent nasal inflammation from untreated pollinosis can impair sinus drainage, leading to recurrent or chronic bacterial sinusitis requiring antibiotic or surgical intervention.
Asthma development or exacerbation
Long-term untreated allergic rhinitis is associated with a 2–3-fold increased risk of developing asthma; patients with existing asthma face predictable fall exacerbations.
Nasal polyps
Chronic allergic inflammation can lead to the formation of nasal polyps, which further obstruct nasal passages and impair sense of smell.
Sleep disruption and fatigue
Nocturnal nasal congestion causes poor sleep quality, leading to daytime fatigue, reduced productivity, and impaired quality of life.
Oral allergy syndrome
Cross-reactivity between Amb a 1 and homologous proteins in melons, bananas, and zucchini may cause oral tingling and lip swelling; typically mild and self-limited.
What Causes Carelessweed Reactions?
Carelessweed pollen allergy is caused by IgE antibodies generated against the pollen proteins of Ambrosia psilostachya. The dominant allergen is Amb a 1, a 38 kDa pectate lyase that shares high sequence homology with the Amb a 1 allergen from common ragweed (Ambrosia artemisiifolia). This structural similarity means that patients sensitized to carelessweed are almost universally cross-reactive to common ragweed, giant ragweed, and other Ambrosia species — the entire genus shares a common allergen profile.
Carelessweed / western ragweed / perennial ragweed
Ambrosia psilostachya
Common ragweed / short ragweed
Ambrosia artemisiifolia
Giant ragweed
Ambrosia trifida
Flatspine bur ragweed
Ambrosia acanthicarpa
How it works
Carelessweed pollen allergy follows the classic Type I (IgE-mediated) hypersensitivity pathway. Amb a 1, a pectate lyase protein, is taken up by antigen-presenting cells in the nasal mucosa and presented to T-helper cells, which drive B-cell production of Amb a 1-specific IgE. These IgE antibodies bind to high-affinity FcεRI receptors on mast cells and basophils. Upon re-exposure to carelessweed pollen, Amb a 1 cross-links surface IgE, triggering mast cell degranulation with release of histamine, leukotrienes, and prostaglandins that produce the characteristic symptoms of rhinoconjunctivitis.
Carelessweed produces enormous quantities of pollen per plant — estimates suggest a single mature plant can release billions of pollen grains over a season. The pollen is lightweight, dry, and designed for wind dispersal, traveling hundreds of miles from its source. In the Great Plains, where carelessweed is the dominant fall weed, pollen counts can reach extremely high levels during August–October, making it a primary driver of fall hay fever in that region.
Patients with existing ragweed sensitization who move to the Great Plains may experience worsening symptoms during the fall season due to the additional burden of carelessweed pollen, even though the molecular target (Amb a 1) is essentially the same. The clinical significance of carelessweed is therefore largely geographic — it extends the ragweed pollen season and increases the total pollen load in regions where it is the dominant species.
Risk factors to watch for
Residence in the US Great Plains
Carelessweed is the dominant fall aeroallergen in the Great Plains, from Texas through the Dakotas, where it grows as a perennial weed in disturbed soils.
Existing ragweed sensitization
Patients already sensitized to common ragweed (Amb a 1) are universally cross-reactive to carelessweed due to shared allergen structure.
Outdoor occupations and activities
Farmers, construction workers, and outdoor enthusiasts in the Great Plains have higher exposure to carelessweed pollen during the August–October season.
Family history of atopy
A personal or family history of allergic rhinitis, asthma, or eczema increases the likelihood of developing sensitization to any aeroallergen, including carelessweed.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
How to Diagnose Carelessweed Allergy
Diagnosing carelessweed allergy follows the same approach as diagnosing any seasonal pollen allergy. The first step is a detailed clinical history: symptoms that consistently occur from August through October in the Great Plains or Southwest, particularly on warm, dry, windy days, are highly suggestive of Ambrosia pollen allergy. The specific identification of carelessweed versus common ragweed is less important clinically than confirming sensitization to Ambrosia species as a group. Skin prick testing with standardized ragweed extract is the most common diagnostic approach. Because Amb a 1 from common ragweed is structurally nearly identical to Amb a 1 from carelessweed, a positive skin test to ragweed extract confirms sensitization to the entire Ambrosia genus — including carelessweed. Specific IgE blood testing (ImmunoCAP) for ragweed is also widely available and provides quantitative results. At-home allergy testing services such as Curex offer panels covering 40+ environmental allergens including ragweed, with results typically within 5 days and insurance coverage often available. This allows patients in the Great Plains to confirm their sensitization profile without an in-clinic visit. A board-certified allergist can then interpret results in the context of local pollen calendars and develop a comprehensive treatment plan.
Skin prick test with standardized ragweed extract
A small amount of commercial ragweed extract is placed on the forearm or back and the skin is pricked. A wheal-and-flare reaction within 15–20 minutes indicates IgE sensitization to Ambrosia species, including carelessweed.
Specific IgE blood test (ImmunoCAP)
A blood sample is tested for IgE antibodies to ragweed (w1). Quantitative results (kU/L) correlate with likelihood of clinical reactivity.
Component-resolved diagnostics (Amb a 1)
Molecular testing for IgE to the specific Amb a 1 protein can confirm that sensitization is driven by the major allergen rather than minor cross-reactive components.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizCompare Treatment Options
See how different approaches stack up for managing your allergy symptoms long-term.
Traditional
Allergy Shots (SCIT)
Immunotherapy (SLIT)
RecommendedTreats root cause
Long-lasting relief
At-home treatment
No office visits
Low side effects
Estimated cost
Traditional
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Allergy Shots (SCIT)
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Immunotherapy (SLIT)
Recommended- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
The long-term solution to allergies
Instead of masking symptoms, immunotherapy retrains your immune system.
If you've been managing fall allergy symptoms with antihistamines and nasal sprays for years and still find yourself miserable every August through October, allergen immunotherapy offers a disease-modifying alternative that targets the underlying immune response rather than just masking symptoms. Because carelessweed shares the major allergen Amb a 1 with common ragweed (Ambrosia artemisiifolia), standard ragweed immunotherapy extracts — which are widely available and FDA-approved — are fully effective for carelessweed sensitization. No separate carelessweed extract is needed. Both subcutaneous immunotherapy (SCIT, allergy shots) and sublingual immunotherapy (SLIT, drops or tablets) are available for ragweed. Sublingual immunotherapy drops, offered by providers like Curex starting at $39/month, allow patients to undergo desensitization at home without weekly clinic visits, and plans are typically covered by most insurance. The treatment course typically spans 3–5 years, with most patients experiencing significant symptom improvement within the first 6–12 months. Clinical trials of ragweed immunotherapy consistently demonstrate 60–80% reduction in seasonal symptom scores, and the benefits persist for years after treatment is completed.
Confirm Ambrosia sensitization
Skin prick test or specific IgE blood test confirms sensitization to ragweed/carelessweed. Component testing for Amb a 1 can confirm primary sensitization.
Select immunotherapy route
Discuss with your allergist whether SCIT (shots, in-clinic) or SLIT (drops, at-home) better fits your lifestyle, schedule, and preferences.
Begin build-up phase
Gradually increasing doses of ragweed extract are administered over 3–6 months to build immune tolerance without triggering severe reactions.
Maintenance phase
Once the target dose is reached, regular maintenance doses continue for 3–5 years to sustain immune tolerance and long-term symptom relief.
“Clinical trials demonstrate 60–80% reduction in seasonal rhinoconjunctivitis symptom scores with ragweed immunotherapy”
Treat your Carelessweed allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- 4.8/5Patient rating
- From $39/moWith insurance
- 50K+Patients treated
- HSA/FSAEligible
Living With Carelessweed Allergy
Managing carelessweed allergy is straightforward with the right approach. The most important step is confirming the diagnosis — if you live in the Great Plains and experience predictable August–October symptoms, you almost certainly have Ambrosia pollen allergy. Once confirmed, a combination of pre-season medication, daily environmental controls, and allergen immunotherapy can transform your fall experience from misery to manageable. Creating a symptom diary during the pollen season helps document which days are worst and correlates with local pollen count data. This information is invaluable for your allergist in adjusting your treatment plan. For patients on immunotherapy, tracking symptom improvement over successive seasons provides motivation and objective evidence of treatment success. For families with children who have carelessweed allergy, the back-to-school period (August–September) coincides with peak pollen season. Working with the school nurse to ensure medication access, keeping windows closed in the classroom, and scheduling outdoor recess for later in the day when pollen counts are lower can help children stay focused and comfortable during the school day.
Pre-season planning
Start intranasal corticosteroids 1–2 weeks before the August pollen season begins. Stock up on antihistamines and eye drops. Schedule your immunotherapy build-up phase to begin in spring or early summer.
Daily pollen tracking
Check local pollen counts every morning during August–October. Plan outdoor activities for late afternoon or after rain, when counts are lowest. Keep windows closed on high-count days.
School and workplace accommodations
Discuss medication access with school nurses or workplace health services. Request indoor lunch and recess on high pollen days for children. Consider air purifiers for office or classroom spaces.
Track your progress
Keep a symptom diary during the fall season to document which days are worst. This data helps your allergist adjust your treatment plan and provides objective evidence of immunotherapy success.
Seasonal Patterns
August
medium intensity
September - October
high intensity
November
low intensity
Prevention Tips
Monitor local pollen counts
Use the National Allergy Bureau or weather app pollen tracking to identify high-count days and proactively limit outdoor exposure.
Keep windows closed in peak season
Close windows and use air conditioning with HEPA filtration during August–October to keep indoor pollen levels low.
Shower after outdoor exposure
Showering and changing clothes after time outdoors removes pollen from hair, skin, and clothing that would continue causing indoor exposure.
Pre-season medication start
Beginning intranasal corticosteroids 1–2 weeks before the expected pollen season (mid-August) reduces the initial inflammatory response and controls symptoms more effectively.
Avoid raw cross-reactive foods
During the pollen season, avoid raw melons, bananas, and zucchini if you experience oral allergy symptoms; cooking these foods resolves the issue.
Outlook for Carelessweed Allergy
The prognosis for carelessweed allergy is generally favorable with appropriate management. Most patients achieve adequate symptom control with standard pharmacotherapy during the 3-month pollen season. For patients pursuing allergen immunotherapy, the outlook is excellent — clinical trials demonstrate 60–80% long-term symptom reduction, and the benefits persist for years after treatment completion. Because carelessweed shares the major allergen Amb a 1 with common ragweed, immunotherapy options are well-established and widely available. The oral allergy syndrome associated with cross-reactive foods is typically mild and easily managed by avoiding raw forms of trigger foods during the pollen season. The condition does not typically worsen over time, and many patients find that their symptoms stabilize or even improve with consistent management.
Key takeaways
Carelessweed allergy is a major fall aeroallergen in the US Great Plains, driven by the Amb a 1 allergen shared with common ragweed
Standard ragweed immunotherapy extracts are fully effective for carelessweed sensitization due to shared allergen structure
Clinical trials demonstrate 60–80% symptom reduction with ragweed immunotherapy, with benefits persisting for years after treatment
Oral allergy syndrome from cross-reactive foods (melons, bananas, zucchini) is typically mild and managed by cooking trigger foods
Diet and Carelessweed Cross-Reactivity
Dietary cross-reactivity is a consideration for carelessweed allergy, driven by the Amb a 1 allergen. Amb a 1 is a pectate lyase that shares structural homology with proteins found in certain fruits and vegetables. Patients with Ambrosia sensitization may experience oral allergy syndrome (tingling, itching, or mild swelling of the lips, mouth, or throat) when eating raw melons (cantaloupe, honeydew, watermelon), bananas, and zucchini. These symptoms are typically mild, self-limited, and resolve within 15–30 minutes without treatment. Cooking denatures the cross-reactive proteins, so cooked versions of these foods are usually well-tolerated. Patients who experience more severe symptoms such as throat swelling or difficulty breathing should discuss this with their allergist, as it may indicate a primary food allergy rather than cross-reactivity.
Foods to limit
Raw melons (cantaloupe, honeydew, watermelon)
Amb a 1 cross-reactivity with homologous proteins in melons may cause oral tingling and lip swelling during the pollen season.
Raw bananas
Bananas contain proteins that cross-react with Amb a 1, potentially causing oral allergy syndrome in sensitized patients.
Raw zucchini
Zucchini and other Cucurbitaceae family members share cross-reactive proteins with Ambrosia pollen; cooking resolves the issue.
Frequently Asked Questions
Carelessweed (Ambrosia psilostachya) is a distinct species within the Ambrosia genus, but it is closely related to common ragweed (Ambrosia artemisiifolia) and giant ragweed (Ambrosia trifida). The major allergen, Amb a 1, is structurally and immunologically nearly identical across all Ambrosia species. This means that patients sensitized to one species are universally cross-reactive to all others. For clinical purposes, carelessweed allergy is essentially ragweed allergy — the same symptoms, the same treatment approach, and the same immunotherapy extracts work for both. The practical difference is geographic: carelessweed is the dominant Ambrosia species in the Great Plains, while common ragweed dominates in the eastern US.
Yes, carelessweed pollen can trigger asthma exacerbations in sensitized patients. The Amb a 1 allergen, when inhaled, can reach the lower airways and trigger bronchoconstriction. Studies of ragweed pollen demonstrate that emergency department visits for asthma increase by 10–30% during the fall pollen season, and hospitalizations for asthma peak in September — a phenomenon known as the 'September asthma epidemic.' Patients with known asthma living in the Great Plains should have a written asthma action plan and pre-treat with controller medications before the August–October pollen season. If you experience wheezing, chest tightness, or shortness of breath during the fall season, discuss these symptoms with your allergist.
Carelessweed pollen season typically runs from August through October, with peak counts in September. The exact duration varies by latitude: in the southern Great Plains (Texas, Oklahoma, Kansas), the season can extend into early November during warm autumns, while in the northern Great Plains (Nebraska, Dakotas), the season ends by mid-October with the first hard frost. The season begins slightly earlier than common ragweed in some regions because carelessweed is a perennial that emerges earlier in the spring. Patients in the central US often experience a prolonged fall allergy season driven by multiple Ambrosia species that together span August through November.
Local honey is often promoted as a natural remedy for pollen allergies, but the evidence supporting this claim is limited. Commercial honey contains minimal pollen proteins after processing, and the pollen in honey is primarily from insect-pollinated flowers, not wind-pollinated weeds like carelessweed. No peer-reviewed studies demonstrate that consuming local honey reduces allergic rhinitis symptoms from Ambrosia pollen. Patients with carelessweed allergy can safely eat honey, but they should not expect it to provide meaningful symptom relief. Standard pharmacotherapy and allergen immunotherapy remain the evidence-based treatments for pollen allergy.
There is no cure for carelessweed allergy, but allergen immunotherapy (allergy shots or sublingual drops) is a disease-modifying treatment that can induce long-term immune tolerance. Clinical trials demonstrate that 3–5 years of ragweed immunotherapy produces 60–80% reduction in symptom scores, and the benefits persist for years after treatment is completed. This is the closest available approach to a 'cure' — it fundamentally changes the immune system's response to the allergen rather than just masking symptoms. For patients who complete the full course of immunotherapy, many experience sustained relief even after treatment ends.
Patients with carelessweed allergy may experience oral allergy syndrome (tingling, itching, or mild swelling of the lips, mouth, or throat) when eating certain raw fruits and vegetables during the pollen season. The most common triggers are melons (cantaloupe, honeydew, watermelon), bananas, and zucchini. These reactions are caused by cross-reactivity between the Amb a 1 allergen and homologous proteins in these foods. The symptoms are typically mild and self-limited, resolving within 15–30 minutes without treatment. Cooking denatures the cross-reactive proteins, so cooked versions of these foods are usually well-tolerated. If you experience more severe symptoms such as throat swelling or difficulty breathing, seek emergency care immediately.
Yes, new-onset pollen allergies can develop at any age, including middle adulthood and beyond. The mechanism is the same regardless of age: repeated exposure to pollen in a genetically susceptible individual can eventually drive IgE sensitization and symptomatic rhinoconjunctivitis. Adults who relocate to the Great Plains and experience their first fall respiratory symptoms after the move may be developing new Ambrosia sensitization driven by regional exposure they did not have previously. This clinical presentation — 'I never had allergies before I moved to Kansas' — should prompt evaluation with a regional pollen panel and is entirely consistent with adult-onset sensitization.
Carelessweed and western ragweed are common names for the same plant: Ambrosia psilostachya. The plant is also called perennial ragweed because it is a perennial that spreads through underground rhizomes, unlike common ragweed (Ambrosia artemisiifolia), which is an annual that must re-seed each year. The name 'carelessweed' is thought to originate from the plant's tendency to grow in disturbed, neglected soils — 'careless' land. The plant is native to the Great Plains and is the dominant Ambrosia species in that region. Regardless of the common name used, the clinical significance is the same: it produces large quantities of highly allergenic pollen containing the Amb a 1 allergen.
Carelessweed allergy is diagnosed through standard allergy testing methods. Skin prick testing with commercial ragweed extract is the most common approach — because Amb a 1 is shared across all Ambrosia species, a positive test to ragweed confirms sensitization to carelessweed as well. Specific IgE blood testing (ImmunoCAP) for ragweed is also widely available. Component-resolved diagnostics for Amb a 1 can confirm that sensitization is driven by the major allergen rather than cross-reactive pan-allergens. At-home allergy testing services such as Curex offer panels covering ragweed and other environmental allergens, with results typically within 5 days. A board-certified allergist can interpret results in the context of local pollen calendars.
Carelessweed pollen allergy typically causes respiratory symptoms (rhinoconjunctivitis, asthma) rather than skin symptoms. However, direct skin contact with the plant itself — not just the pollen — can cause a contact dermatitis in some individuals. The Ambrosia genus contains sesquiterpene lactones, which are known contact allergens that can cause a delayed-type hypersensitivity reaction (poison ivy-like rash) in sensitized individuals. This is distinct from the IgE-mediated respiratory allergy and involves a different immune mechanism (Type IV hypersensitivity). Patients who develop a rash after handling carelessweed plants should discuss this with their allergist or dermatologist, as it may represent a separate contact allergy rather than a pollen allergy.
Medical References
- [1]Boulet LP, Turcotte H, Laprise C, et al. Comparative degree and type of sensitization to common indoor and outdoor allergens in subjects with allergic rhinitis and/or asthma. Clin Exp Allergy 1997;27(1):52–59.
- [2]D'Amato G, Cecchi L, Bonini S, et al. Allergenic pollen and pollen allergy in Europe. Allergy 2007;62(9):976–990.
- [3]Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update. Allergy 2008;63 Suppl 86:8–160.
- [4]Gergen PJ, Turkeltaub PC, Kovar MG. The prevalence of allergic skin test reactivity to eight common aeroallergens in the U.S. population: results from the second National Health and Nutrition Examination Survey. J Allergy Clin Immunol 1987;80(5):669–679.
- [5]CalderĂłn MA, Alves B, Jacobson M, et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007;(1):CD001936.
- [6]Radulovic S, Wilson D, Calderón M, Durham S. Systematic reviews of sublingual immunotherapy (SLIT). Allergy 2011;66(6):740–752.
- [7]American Academy of Allergy, Asthma & Immunology (AAAAI). Ragweed allergy.
- [8]American College of Allergy, Asthma & Immunology (ACAAI). Ragweed allergy.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Carelessweed allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
